![Torben Nissen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Torben Nissen
Founder at
Flagship Labs 84, Inc.
Profile
Dr. Torben S.
Nissen is a Chairman & Chief Executive Officer at Repertoire Immune Medicines, Inc., a Chairman at Etiome, Inc., an Executive Partner at Flagship Pioneering, Inc. and a Chief Executive Officer, Treasurer & Director at Torque Therapeutics, Inc. He is on the Board of Directors at Torque Therapeutics, Inc. Dr. Nissen was previously employed as an Independent Director by Axcella Health, Inc., a President by VL26, INC., a Head-Worldwide Research & Development by Pfizer Inc., a Chief Operating Officer & Executive Director by Centers for Therapeutic Innovation, a Chief Operating Officer by Ascendis Pharma A/S, a Managing Director by Maxygen, Inc., a President by Moksha8 Pharmaceuticals, Inc., and a Principal by Novo Nordisk A/S.
He also served on the board at Ring Therapeutics, Inc. He received his graduate degree from Technical University of Denmark and a doctorate degree from Technical University of Denmark.
Torben Nissen active positions
| Companies | Position | Start |
|---|---|---|
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 2016-10-31 |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Chief Executive Officer | 2023-12-31 |
Flagship Labs 84, Inc.
 Flagship Labs 84, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Founder | 2020-12-31 |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Chief Executive Officer | - |
Former positions of Torben Nissen
| Companies | Position | End |
|---|---|---|
| AXCA HEALPAR | Director/Board Member | 2023-10-31 |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Director/Board Member | 2021-11-30 |
| RUBIUS THERAPEUTICS | President | 2019-07-23 |
| PFIZER INC. | Corporate Officer/Principal | 2016-10-31 |
Centers for Therapeutic Innovation | Chief Operating Officer | 2013-12-31 |
Training of Torben Nissen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Moksha8 Pharmaceuticals, Inc.
 Moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes medicines | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Centers for Therapeutic Innovation | |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Flagship Labs 84, Inc.
Flagship Labs 84, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
- Stock Market
- Insiders
- Torben Nissen
